HighCape Capital
HighCape Capital is a growth equity firm based in Westport, Connecticut, with an additional office in Baltimore, Maryland. Founded in 2013, the firm specializes in investing in commercial-stage life sciences companies that are in the early revenue or product launch phase. HighCape focuses on businesses that offer high-margin products with the potential to deliver significant value to the healthcare system. The firm aims to transform its portfolio companies into scalable commercial entities, facilitating their growth and sustainability while providing multiple exit options. HighCape's investment strategy encompasses sectors such as healthcare devices, pharmaceuticals, and biotechnology.
Wellinks is a medical technology company that specializes in the design and development of medical devices aimed at improving respiratory health. Founded in 2014 and headquartered in Fairfield, Connecticut, the company offers innovative solutions, including Flyp, a handheld nebulizer specifically designed for patients with respiratory diseases. Wellinks operates within the health and wellness sector, focusing on enhancing the quality of care for individuals suffering from such conditions.
Cybrexa, Inc. develops DNA repair inhibitors for radio- and chemo-sensitizers in cancer therapeutics. The product consists of peptide-based technology that directly targets tumor microenvironment. Cybrexa, Inc. was formerly known as Cybrexa, Inc. The company was founded in 2016 and is based in New Haven, Connecticut.
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Its focus is on leveraging the synthetic lethal context of certain cancer patient subsets that have NAD Metabolic Deficiencies (NMD) through the development of companion diagnostics. Their goal is to develop best-in-class targeted therapies against the NAD pathway nodes in patients whose cancers exhibit hallmarks of NMD and rapidly translate these into the clinic.
Flyp Nebulizer, the medical device is reinvented by Weblinks for respiratory care around the people who need it most. It works at ultrasonic speed to create a fine aerosol of medication. Flyp Nebulizer works quickly to deliver treatment within 7-minute average.
Wellinks is a medical technology company that specializes in the design and development of medical devices aimed at improving respiratory health. Founded in 2014 and headquartered in Fairfield, Connecticut, the company offers innovative solutions, including Flyp, a handheld nebulizer specifically designed for patients with respiratory diseases. Wellinks operates within the health and wellness sector, focusing on enhancing the quality of care for individuals suffering from such conditions.
Cybrexa, Inc. develops DNA repair inhibitors for radio- and chemo-sensitizers in cancer therapeutics. The product consists of peptide-based technology that directly targets tumor microenvironment. Cybrexa, Inc. was formerly known as Cybrexa, Inc. The company was founded in 2016 and is based in New Haven, Connecticut.
Cybrexa, Inc. develops DNA repair inhibitors for radio- and chemo-sensitizers in cancer therapeutics. The product consists of peptide-based technology that directly targets tumor microenvironment. Cybrexa, Inc. was formerly known as Cybrexa, Inc. The company was founded in 2016 and is based in New Haven, Connecticut.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.